H. Diedrich

4.6k citations
34 papers · 2.8k · 3 hit papers · h-index 19

Impact in

Papers in

H. Diedrich

33 papers receiving 2.7k citations

Hit Papers

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia 2018 · 516 citations
5160+12+25Years since publication100200300400500

Peers

H. Diedrich
Comparison fields: 5 of 70
  • Hematology 1.4k
  • Public Health, Environmental and Occupational Health 1.6k
  • Oncology 1.3k
  • Genetics 345
  • Pathology and Forensic Medicine 457
Replace Heinz‐August Horst with:
Heinz‐August Horst Germany
Christoph Faul Germany
Thorsten Raff Germany
Richard Ratei Germany
Cornelia Eckert Germany
FG Behm United States
Hermann Kreyenberg Germany
Akihiro Tsuboi Japan
RK Dodge United States
DJ Pullen United States
H. Diedrich relative to Heinz‐August Horst Germany Heinz‐August Horst's profile →
Citations per field
00.5×1.5×
Heinz‐August Horst · 1×
Citations per year

Countries citing papers authored by H. Diedrich

Since Specialization
Citations

This map shows the geographic impact of H. Diedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Diedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Diedrich more than expected).

Fields of papers citing papers by H. Diedrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Diedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Diedrich. The network helps show where H. Diedrich may publish in the future.

Co-authors

The 25 scholars most cited alongside H. Diedrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Diedrich Line = papers co-authored together H. Diedrich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
Hit paper breakdown →
2018516
2
Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
Hit paper breakdown →
2014488
3
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
Hit paper breakdown →
1988430
4 2012321
5 1998132
6 2011126
7 1996122
8 2015115
9 198975
10 201144
11 200844
12 201043
13 201539
14 199734
15 199631
16 200731
17
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
199026
18 199620
19 200820
20 201216

About H. Diedrich

H. Diedrich is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Immunology and Oncology, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (16 papers), Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), CAR-T cell therapy research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Hematology (1.4k citations), Public Health, Environmental and Occupational Health (1.6k citations), Oncology (1.3k citations), Genetics (345 citations) and Pathology and Forensic Medicine (457 citations). H. Diedrich has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Nicola Gökbuget, Albrecht Reichle, Heinz‐August Horst, Mathias Freund, Monika Brüggemann, Ralf C. Bargou, Max S. Topp, Christoph Faul, Gerhard Zugmaier and Dieter Hoelzer. Their work appears in journals such as Blood, Annals of Hematology, British Journal of Haematology, Cancer Chemotherapy and Pharmacology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact